Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Covid-19’S Immuno-Pathology and Cardiovascular Diseases Publisher Pubmed



Nasab EM1, 2 ; Aghajani H1 ; Makoei RH3 ; Athari SS4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cardiology, School of Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Cardiology, School of Medicine, Valiasr Hospital, Zanjan University of Medical Sciences, Zanjan, Iran
  3. 3. Department of Cardiology, School of Medicine, Ayatollah Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran
  4. 4. Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

Source: Journal of Investigative Medicine Published:2023


Abstract

The pandemic of COVID-19 in worldwide causes recent millions of morbidity and mortality in all countries and is the most important challenge in the world in recent years. Coronavirus is a single-stranded RNA virus and infection with COVID-19 leads to acute respiratory distress syndrome, lung inflammation, cytokine storm, and death. The other complications include endothelial dysfunction, activation of coagulation, thromboembolic events, and vascular disease. Cardiovascular complications such as myocardial and stroke ischemia, pulmonary thromboembolism, systemic arterial, and deep vein thrombosis were reported. In this review, we presented immuno-pathological mechanisms and the effects of COVID-19 on the cardiovascular system, heart, vessels, coagulation system, and molecular glance of immuno-inflammation to the COVID-19’s pathology on the cardiovascular system. © 2023 American Federation for Medical Research.
Related Docs
View other Related Docs
1. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
2. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)
3. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
4. Cardiovascular Complications of Covid-19: Pharmacotherapy Perspective, Cardiovascular Drugs and Therapy (2021)
5. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)
6. Coagulopathy: Another Side Effect of Coronavirus Infection, Journal of Cardiovascular and Thoracic Research (2021)
7. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
8. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (30)
Mohammadreza Salehi (10)
Other Related Docs
9. Association Between Cardiometabolic Risk Factors and Covid-19 Susceptibility, Severity and Mortality: A Review, Journal of Diabetes and Metabolic Disorders (2021)
10. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
11. The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran, International Journal of Hematology-Oncology and Stem Cell Research (2023)
12. Molecular Signaling Pathways, Pathophysiological Features in Various Organs, and Treatment Strategies in Sars-Cov2 Infection, Acta Histochemica (2022)
13. Venous Thromboembolism in Viral Diseases: A Comprehensive Literature Review, Health Science Reports (2023)
14. Pharmacotherapy Consideration of Thrombolytic Medications in Covid-19-Associated Ards, Journal of Intensive Care (2022)
15. Cardiovascular Disease in Covid-19: A Systematic Review and Meta-Analysis of 10,898 Patients and Proposal of a Triage Risk Stratification Tool, Egyptian Heart Journal (2020)
16. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
17. Covid-19 and Cardiovascular Diseases, Advances in Experimental Medicine and Biology (2021)
18. State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2, ACS Applied Materials and Interfaces (2021)
19. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the Sars-Cov-2 Cytokine Storm, Current Pharmaceutical Design (2021)
20. Immunosenescence and Inflamm-Ageing in Covid-19, Ageing Research Reviews (2023)
21. Complement System As the Potential Therapeutic Target in the Management of Covid-19 Patients, Trends in Immunotherapy (2022)
22. Exploration of Blood−Derived Coding and Non-Coding Rna Diagnostic Immunological Panels for Covid-19 Through a Co-Expressed-Based Machine Learning Procedure, Frontiers in Immunology (2022)
23. Pediatric Endocrinopathies Related to Covid-19: An Update, World Journal of Pediatrics (2023)
24. Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials, International Immunopharmacology (2022)
25. Covid-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment, Seminars in Thrombosis and Hemostasis (2023)
26. Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (Covid-19), Journal of Cardiovascular Pharmacology (2020)
27. Immunoediting in Sars-Cov-2: Mutual Relationship Between the Virus and the Host, International Immunopharmacology (2022)
28. Coagulopathy and Thromboembolic Events a Pathogenic Mechanism of Covid-19 Associated With Mortality: An Updated Review, Journal of Clinical Laboratory Analysis (2023)
29. The Role of Inflammation in the Development of Complications Caused by Covid-19: A Review Study, Journal of Payavard Salamat (2022)
30. Pharmacotherapy Considerations in Ckd Patients With Covid-19, a Narrative Review, Iranian Journal of Kidney Diseases (2020)
31. Cytokine Profiles Dynamics in Covid-19 Patients: A Longitudinal Analysis of Disease Severity and Outcomes, Scientific Reports (2025)
32. The Coronavirus Disease 2019 and Effect on Liver Function: A Hidden and Vital Interaction Beyond the Respiratory System, Reviews and Research in Medical Microbiology (2022)
33. Prevalence, Risk Factors and Outcomes Associated With Acute Kidney Injury in Patients Hospitalized for Covid-19: A Comparative Study Between Diabetic and Nondiabetic Patients, Journal of Diabetes Research (2021)
34. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)
35. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
36. Ip-10, Mip1α, Il-6, and Il-1Β As Biomarkers Associated With Disease Severity of Covid-19, Jundishapur Journal of Microbiology (2024)
37. Cytokine Storm in the Pathophysiology of Covid-19: Possible Functional Disturbances of Mirnas, International Immunopharmacology (2021)
38. Biomarker Based Biosensors: An Opportunity for Diagnosis of Covid-19, Reviews in Medical Virology (2022)
39. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
40. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
41. Clinical Course and Outcome in Diabetic Patients With Covid-19, Immunopathologia Persa (2021)
42. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
43. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
44. Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in Covid-19: A Multisystem Disease, Advances in Experimental Medicine and Biology (2021)
45. A Review on Hematologic Malignant Patients Infected With 2019 Novel Coronavirus, Archives of Clinical Infectious Diseases (2020)
46. Endosomal Toll-Like Receptors Intermediate Negative Impacts of Viral Diseases, Autoimmune Diseases, and Inflammatory Immune Responses on the Cardiovascular System, Expert Review of Clinical Immunology (2025)
47. Conquering the Cytokine Storm in Covid-19-Induced Ards Using Placenta-Derived Decidua Stromal Cells, Journal of Cellular and Molecular Medicine (2021)
48. The Controversial Effect of Smoking and Nicotine in Sars-Cov-2 Infection, Allergy# Asthma and Clinical Immunology (2023)
49. Evaluation of Mir-200C-3P and Mir-421-5P Levels During Immune Responses in the Admitted and Recovered Covid-19 Subjects, Infection# Genetics and Evolution (2022)
50. Well-Controlled Vs Poorly-Controlled Diabetes in Patients With Covid-19: Are There Any Differences in Outcomes and Imaging Findings?, Diabetes Research and Clinical Practice (2020)